GlassScriptPhysician profile
Stephen M Chen
NPI 1245313311
$8,561.91
in general payments reported to CMS, 2019-2025
22 companies · $465 in 2025
The $465 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,315 · 2020: $1,371 · 2021: $1,393 · 2022: $772 · 2023: $968 · 2024: $1,277 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,710.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $1,962.11 | 2019-2022 | |
| Davol INC. | $1,234.01 | 2022-2024 | Phasix Mesh, Arista Ah Flexitip |
| Allergan, INC. | $1,194.22 | 2019-2022 | |
| Mentor Worldwide LLC | $1,149.10 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Musculoskeletal Transplant Foundation INC. | $785.21 | 2019-2023 | |
| Revance Therapeutics, INC. | $340.06 | 2024-2025 | Daxxify |
| Tepha INC | $281.44 | 2019 | |
| Apyx Medical Corporation | $250.90 | 2020 | |
| Motiva USA, LLC | $227.10 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $202.54 | 2019-2020 | |
| Abbvie INC. | $182.38 | 2023-2024 | Botox |
| Polynovo North America LLC | $165.68 | 2024 | Novosorb Btm |
| Baxter Healthcare | $133.04 | 2020 | |
| Solta Medical, A Division of Bausch Health US, LLC | $123.41 | 2024 | |
| Tela Bio, INC. | $116.71 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $52.12 | 2022-2024 | V-Loc 180 |
| Integra Lifesciences Corporation | $50.30 | 2020 | |
| Innovation Technologies INC | $29.87 | 2024 | Irrisept |
| Galderma Laboratories, L.P. | $29.68 | 2024 | |
| Misonix INC | $26.98 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.09 | 2019 | |
| W. L. Gore & Associates, INC. | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.